ID   7G7B6
AC   CVCL_J731
SY   7G7/B6
DR   CLO; CLO_0001501
DR   ABCD; ABCD_AJ519
DR   ATCC; HB-8784
DR   NCBI_Iran; H161
DR   Wikidata; Q54605128
RX   Patent=US4707443;
RX   PubMed=2408992;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8784.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
RX   Patent=US4707443;
RA   Nelson D.L., Biddison W.E., Rubin L.A., Greene W.C., Leonard W.J.,
RA   Yarchoan R.;
RT   "Soluble interleukin-2 receptor as a disease indicator and a method of
RT   assaying the same.";
RL   Patent number US4707443, 17-Nov-1987.
//
RX   PubMed=2408992; DOI=10.1089/hyb.1985.4.91;
RA   Rubin L.A., Kurman C.C., Biddison W.E., Goldman N.D., Nelson D.L.;
RT   "A monoclonal antibody 7G7/B6, binds to an epitope on the human
RT   interleukin-2 (IL-2) receptor that is distinct from that recognized
RT   by IL-2 or anti-Tac.";
RL   Hybridoma 4:91-102(1985).
//